Rising Incidence of Cancer Driving Oligonucleotide Synthesis Market

Re-publier cet article

<h1>Rising Incidence of Cancer Driving Oligonucleotide Synthesis Market</h1><strong> Author: <a href='http://fr.articleseen.com/profile_Pramod Kumar.aspx'>Pramod Kumar</a></strong><br /><p>According to the estimates of the market research company, P&S Intelligence, the market will progress at a CAGR of 10.8% from 2018 to 2023 (forecast period). The market is being driven by the surging research activities being carried out in synthetic biology, growing incidence of infectious diseases and cancer, rapid advancements and innovations in oligonucleotide synthesis technologies, and implementation of favorable government policies. The advancements in synthesis technologies have resulted in the development of faster and cost-effective oligomer synthesis procedures. Moreover, the development of better coupling reagents, new sets of protecting amino groups, and high-throughput synthesizers has transformed the oligonucleotide synthesis process. Furthermore, the development of the microarray technology has also fueled the oligonucleotide product development of diagnostic and therapeutic applications. For example, numerous oligonucleotide conjugates with biological ligands have been recently researched, which are being increasingly used in the diagnosis of several inherited diseases. Depending on offering, the oligonucleotide synthesis market is divided into reagents and consumables, equipment, and synthesized oligonucleotides. Out of these, the synthesized oligonucleotides category is predicted to demonstrate the highest growth rate in the market throughout the forecast period. This is attributed to the rising trend of contract production of oligonucleotides. When application is taken into consideration, the market is classified into diagnostics, therapeutics, and research. Amongst these, the research category is predicted to demonstrate the fastest growth in the market in the upcoming years. This will be because of the rising adoption of oligonucleotides in the molecular diagnosis process used for diagnosing inherited diseases. Geographically, the Asia-Pacific (APAC) region is expected to be the fastest-growing region in the oligonucleotide synthesis market throughout the forecast period. This is credited to the growing demand for improved health outcomes, rising incidence of infectious and chronic diseases, and improving healthcare infrastructure in the region. As per the World Health Organization (WHO), around 1 million and 3.1 million cancer cases (excluding non-melanoma skin cancer) were reported in India and China, respectively, in 2012. Thus, the rising incidence of infectious and chronic diseases and the increasing research and development (R&D) activities being carried out in the domain of synthetic biology will drive the progress of the market all over the world in the coming years. Access Detailed on Oligonucleotide Synthesis Market Regional and Country Breakdown Report @ https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market </p><strong>About the Author:</strong><br />Pramod has around 7 years of experience in market research and consulting services for healthcare industry. He holds varied experience in market sizing and forecasting with varied models, competition landscape, consumer behavior analysis, opportunity analysis, product/company benchmarking, data mining and others. <p> Article Source: <a href='http://fr.articleseen.com/Article_Rising-Incidence-of-Cancer-Driving-Oligonucleotide-Synthesis-Market_1112.aspx'> http://fr.articleseen.com/Article_Rising Incidence of Cancer Driving Oligonucleotide Synthesis Market_1112.aspx</a></p>

Source de l'article : http://fr.articleseen.com/Article_Rising Incidence of Cancer Driving Oligonucleotide Synthesis Market_1112.aspx

Mots-clés : https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market,

Catégorie : D'affaires : PR